Author:
Jostes Sina,Vardabasso Chiara,Dong Joanna,Carcamo Saul,Singh Rajendra,Phelps Robert,Meadows Austin,Grossi Elena,Hasson Dan,Bernstein Emily
Abstract
High levels of H2A.Z promote melanoma cell proliferation and correlate with poor prognosis. However, the role of the two distinct H2A.Z histone chaperone complexes SRCAP and P400–TIP60 in melanoma remains unclear. Here, we show that individual subunit depletion ofSRCAP,P400, andVPS72(YL1) results in not only the loss of H2A.Z deposition into chromatin but also a reduction of H4 acetylation in melanoma cells. This loss of H4 acetylation is particularly found at the promoters of cell cycle genes directly bound by H2A.Z and its chaperones, suggesting a coordinated regulation between H2A.Z deposition and H4 acetylation to promote their expression. Knockdown of each of the three subunits downregulates E2F1 and its targets, resulting in a cell cycle arrest akin to H2A.Z depletion. However, unlike H2A.Z deficiency, loss of the shared H2A.Z chaperone subunit YL1 induces apoptosis. Furthermore, YL1 is overexpressed in melanoma tissues, and its upregulation is associated with poor patient outcome. Together, these findings provide a rationale for future targeting of H2A.Z chaperones as an epigenetic strategy for melanoma treatment.
Funder
National Institutes of Health
Clinical and Translational Science Awards
National Center for Advancing Translational Sciences
Office of Research Infrastructure
Deutsche Forschungsgemeinschaft
American Skin Association Research Grant for Skin Cancer and Melanoma
Howard Hughes Medical Institute Medical Research Fellows Award
National Cancer Institute/NIH
Publisher
Cold Spring Harbor Laboratory